Balchem Corporation to Attend the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on January 14, 2026
Rhea-AI Summary
Balchem (NASDAQ: BCPC) will participate in the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on January 14, 2026. Company representatives attending include Ted Harris (chairman, president and CEO), Martin Bengtsson (CFO) and Allison Baurichter (senior director, investor relations). The virtual presentation provides an opportunity for management to discuss strategy and engage with investors.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, BCPC gained 0.43%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers in Specialty Chemicals showed mixed moves: SXT -0.67%, CBT +0.06%, ESI -1.07%, SSL -0.46%, AXTA -1.07%. With no momentum flags or related peer headlines, BCPC’s move appears more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 22 | Regulatory trade action | Positive | +0.5% | EU imposed anti-dumping duties on Chinese choline chloride imports. |
| Dec 10 | Dividend increase | Positive | +2.4% | Annual dividend of $0.96 per share, up 10.3%, 17th consecutive increase. |
| Oct 30 | Investor conference | Neutral | +0.2% | Management presentation at Baird’s Global Industrial Conference announced. |
| Oct 21 | Earnings results | Positive | +4.1% | Q3 2025 results showed higher sales, earnings, EBITDA, and reduced net debt. |
| Oct 07 | Earnings call notice | Neutral | -1.4% | Scheduled Q3 2025 earnings conference call with release timing details. |
Recent history shows positive reactions to fundamental and shareholder-friendly updates (earnings, dividends, regulatory developments), while routine communications like scheduling calls have seen occasional negative divergence.
Over the last several months, Balchem has reported stronger Q3 2025 results with higher net sales, earnings, and reduced leverage, and later detailed these in its 10-Q and 8-K. The company also announced a $0.96 annual dividend, marking a 10.3% increase and the 17th consecutive raise. EU anti-dumping duties on Chinese choline chloride were welcomed by Balchem and a partner. Prior conference appearances highlighted ongoing investor outreach, similar in nature to today’s conference attendance news.
Market Pulse Summary
This announcement highlights Balchem’s continued investor outreach, with senior executives participating in a virtual conference on January 14, 2026. Recent history includes stronger Q3 2025 results, a dividend raised to $0.96 per share, and supportive EU trade measures on choline chloride. Investors may monitor upcoming presentations for any incremental commentary versus prior filings, while also tracking trends in earnings, cash flow, capital allocation, and industry demand across its nutrition and specialty product segments.
AI-generated analysis. Not financial advice.
MONTVALE, N.J., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on January 14, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will attend the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Contact: Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)
FAQ
When will Balchem (BCPC) present at the CJS Securities virtual conference?
Which Balchem executives will attend the January 14, 2026 CJS Securities conference?
How can investors access Balchem's presentation at the CJS Securities virtual conference?
Will Balchem (BCPC) provide new financial guidance at the January 14, 2026 conference?
Is the Balchem (BCPC) presentation at the CJS Securities conference open to the public?
